How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Enzyme Activity Assay Service Market
- By Assay Type: Colorimetric Assay, Fluorometric Assay, Luminescent Assay, Radioisotopic Assay, Spectrophotometric Assay
- By Enzyme Class: Hydrolases, Oxidoreductases, Transferases, Lyases, Isomerases, Ligases
- By End-user: Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations (CROs), Food and Beverage Industry, Environmental Testing Laboratories
- By Application: Drug Discovery and Development, Clinical Diagnostics, Food Quality Control, Environmental Monitoring, Biochemical Research
- By Service Model: Custom Enzyme Assay Development, High-throughput Screening Services, Kinetic Enzyme Activity Analysis, Enzyme Inhibition Studies, Enzyme Profiling and Characterization
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Colorimetric Assay leads By Assay Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 308 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.187 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.195 →
Full report · locked preview
Everything inside the Enzyme Activity Assay Service Market report
A complete, evidence-based study - 12 chapters and 129 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Assay Type 5
Enzyme Class 6
End-user 5
Application 5
Service Model 5
Companies profiled
Eurofins Scientific
Charles River Laboratories
SGS SA
WuXi AppTec
LabCorp
Covance (LabCorp Drug Development)
Q2 Solutions
ICON plc
Pace Analytical Services
BioReliance (Merck KGaA)
Toxikon Corporation
Frontage Laboratories
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Eurofins Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Charles River Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →SGS SA
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →WuXi AppTec
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →LabCorp
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Covance (LabCorp Drug Development)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Q2 Solutions
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →ICON plc
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Pace Analytical Services
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →BioReliance (Merck KGaA)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Toxikon Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Frontage Laboratories
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Pharmaron
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Syngene International
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Evotec SE
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$848.0M by 2033 · 4.9% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Colorimetric Assay47.8
- Fluorometric Assay8.9
- Luminescent Assay15.8
- Radioisotopic Assay19.6
- Spectrophotometric Assay7.9
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$191.2M → $259.0M · 3.9%
Europe$133.3M → $192.7M · 4.7%
Asia Pacific$121.7M → $168.5M · 4.2%
Latin America$75.3M → $112.3M · 5.1%
Middle East and Africa$58.0M → $75.1M · 3.3%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →4.832026
4.842027
4.852028
4.862029
4.872030
4.892031
4.912032
4.912033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Eurofins Scientific12.3
- Charles River Laboratories16.2
- SGS SA11.8
- WuXi AppTec13.1
- LabCorp7.5
- Covance (LabCorp Drug Development)11.1
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Assay Type16.2%
Enzyme Class24.4%
End-user24.4%
Application17.8%
Service Model17.3%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.1
- Europe23.9
- Asia Pacific20.9
- Latin America13.9
- Middle East and Africa9.3
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Eurofins Scientific | 88 | 85 | 95 | 81 | 98 | 91 | 90 |
| Charles River Laboratories | 82 | 87 | 90 | 73 | 92 | 84 | 85 |
| SGS SA | 81 | 75 | 72 | 86 | 84 | 85 | 81 |
| WuXi AppTec | 80 | 60 | 58 | 72 | 69 | 70 | 68 |
| LabCorp | 75 | 58 | 64 | 75 | 58 | 71 | 67 |
| Covance (LabCorp Drug Development) | 62 | 59 | 65 | 53 | 49 | 46 | 56 |
| Q2 Solutions | 44 | 49 | 63 | 47 | 58 | 60 | 54 |
| ICON plc | 45 | 39 | 39 | 39 | 53 | 45 | 43 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Eurofins Scientific
- Charles River Laboratories
- SGS SA
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Eurofins Scientific | ◐ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Charles River Laboratories | ◐ | ✓ | ✓ | ◐ | ✓ | ◐ |
| SGS SA | ✓ | ◐ | ◐ | ✓ | ✓ | ✓ |
| WuXi AppTec | ✓ | ◐ | ◐ | ◐ | ◐ | ✓ |
| LabCorp | ✓ | − | − | − | ◐ | ◐ |
| Covance (LabCorp Drug Development) | − | ◐ | ◐ | ◐ | − | − |
| Q2 Solutions | − | − | − | ◐ | ◐ | ◐ |
| ICON plc | − | − | − | − | ◐ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Eurofins Scientific90
2Charles River Laboratories85
3SGS SA81
4WuXi AppTec68
5LabCorp67
6Covance (LabCorp Drug Development)56
7Q2 Solutions54
8ICON plc43
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Eurofins ScientificCharles River LaboratoriesSGS SA
Challenger2
Strong scale, closing on the leaders.
WuXi AppTecLabCorp
Niche3
Specialists in a single segment or region.
Covance (LabCorp Drug Development)Q2 SolutionsICON plc
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Assay Type in North America, then scale across Enzyme Activity Assay Service Market — a $732M beachhead inside a $11.2B market.
Beachhead (SOM)$732Mobtainable near-term
Serviceable (SAM)$4.16Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Colorimetric Assay
Best fit — highest urgency & budget in Assay Type.
Economic buyer80 fit
Fluorometric Assay
Strong fit — clear ROI and a fast path to value.
End user70 fit
Luminescent Assay
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Assay Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Enzyme Class & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End-user
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel27%
Digital / self-serve20%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Assay Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Enzyme Activity Assay Service Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified44%
Sales qualified24%
Evaluation13%
Closed-won6%
$21.9KCAC
$106KLTV
4.8:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Enzyme Activity Assay Service Market is a resilient opportunity — $6.45B by 2033, compounding at 3.9%.
TAM · 2025$4.75Btoday
TAM · 2033$6.45Bforecast
CAGR3.9%2027–2033
Cumulative$50.1Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$6.45BTotal addressable market
SAM$2.49BServiceable available market
SOM$430MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →3.9% CAGR
Demand compounds through 2033, outpacing GDP across Assay Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Assay Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$6.45BLarge & growingTAM by 2033 at 3.9% CAGR
$2.49BServiceable nowreachable with today’s model
$430MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.03BBear2.5% CAGR
$6.45BBase3.9% CAGR
$8.25BBull5.1% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Enzyme Class optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Enzyme Activity Assay Service Market — a $6.85B market by 2033. Plan: grow share from 8.9% to 14.7%.
Market size · 2033$6.85Btotal addressable
Market CAGR5.4%2027–2033
Target share14.7%from 8.9% today
Revenue ambition$1.01Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.9% | 14.7% | On track |
| Revenue | $654M | $1.01B | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 37.8% | 41.7% | On track |
| Customer retention | 88.8% | 95.8% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Assay Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Enzyme Class capability
A defensible second engine — invest in Enzyme Class to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Assay Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Enzyme Class
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $121M capacity & capability investment
- Greenlight bolt-on M&A in Enzyme Class
- Authorise North America expansion plan
- Fund R&D program for Assay Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossAt risk
- Input-cost & supply riskBehind
- Regulatory / policy changeAt risk
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Enzyme Activity Assay Service Market conversation — a $6.90B market you can size, segment and defend in minutes.
Market size · 2033$6.90Btotal opportunity
Growth9.8%CAGR to 2033
Addressable buyers1,530+accounts in scope
Typical ROI7.6×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Assay Type
Goal Grow share in Assay Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.6×return on cost, year one
< 4 mopayback period
$51K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Eurofins ScientificCharles River LaboratoriesSGS SAWuXi AppTecLabCorpCovance (LabCorp Drug Development)Q2 SolutionsICON plc+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Enzyme Activity Assay Service Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Enzyme Activity Assay Service Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Enzymatic Wound Debridement Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportEnzymatic DNA Synthesis Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportEnzymatic Debridement Ointment Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportEnzymatic Debridement Agents for Wound Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportEnzymatic Assay Kits Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportEnzalutamide API Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportMagnesium Lactate Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportPlatinum Nanoparticles Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportCotton Nonwoven Fabric Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportReusable Ice Packs Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportMedical Grade Foams Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportBioresorbable Polymers Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.